Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group (Q34172212)

31 July 2017

title

Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group (English)

1 reference

31 July 2017

1 reference

Takuya Kamio

1

1 reference

31 July 2017

Etsuro Ito

2

1 reference

31 July 2017

Akira Ohara

3

1 reference

31 July 2017

Yoshiyuki Kosaka

4

1 reference

31 July 2017

Masahiro Tsuchida

5

1 reference

31 July 2017

Hiroshi Yagasaki

6

1 reference

31 July 2017

Hideo Mugishima

7

1 reference

31 July 2017

Hiromasa Yabe

8

1 reference

31 July 2017

Akira Morimoto

9

1 reference

31 July 2017

Shouichi Ohga

10

1 reference

31 July 2017

Hideki Muramatsu

11

1 reference

31 July 2017

Asahito Hama

12

1 reference

31 July 2017

Takashi Kaneko

13

1 reference

31 July 2017

Masayuki Nagasawa

14

1 reference

31 July 2017

Atsushi Kikuta

15

1 reference

31 July 2017

Yuko Osugi

16

1 reference

31 July 2017

Fumio Bessho

17

1 reference

31 July 2017

Tatsutoshi Nakahata

18

1 reference

31 July 2017

Ichiro Tsukimoto

19

1 reference

31 July 2017

Seiji Kojima

20

1 reference

31 July 2017

Japan Childhood Aplastic Anemia Study Group

21

1 reference

31 July 2017

publication date

21 March 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

96

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

814-819

1 reference

Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

An update on the management of severe idiopathic aplastic anaemia in children

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Bone marrow transplantation for aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Mutations in telomerase catalytic protein in Japanese children with aplastic anemia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105642

Association between aplastic anaemia and mutations in telomerase RNA

28 October 2018

1 reference

12 December 2020

Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome

1 reference

12 December 2020

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA

1 reference

12 December 2020

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

12 December 2020

Natural history of moderate aplastic anemia in children

1 reference

12 December 2020

Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party

1 reference

12 December 2020

Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia

1 reference

12 December 2020

Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan

1 reference

12 December 2020

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

1 reference

12 December 2020

Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on

1 reference

12 December 2020

10.3324/HAEMATOL.2010.035600

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference